Page 34 - Read Online
P. 34
Page 12 of 12 Waterford et al. Vessel Plus 2022;6:28 https://dx.doi.org/10.20517/2574-1209.2021.115
42. Nachimuthu S, Assar MD, Schussler JM. Drug-induced QT interval prolongation: mechanisms and clinical management. Ther Adv
Drug Saf 2012;3:241-53. DOI PubMed PMC
43. Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N
Engl J Med 1997;337:1785-91. DOI PubMed
44. Giri S, White CM, Dunn AB, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation
Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet 2001;357:830-6. DOI PubMed
45. Budeus M, Hennersdorf M, Perings S, et al. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass
grafting: a prospective, double-blinded, placebo-controlled, randomized study. Eur Heart J 2006;27:1584-91. DOI PubMed
46. Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR. Intravenous amiodarone for the prevention of atrial fibrillation after open
heart surgery: the amiodarone reduction in coronary heart (ARCH) trial. J Am Coll Cardiol 1999;34:343-7. DOI PubMed
47. Beaulieu Y, Denault AY, Couture P, et al. Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in
patients undergoing cardiac valvular surgery. Anesthesiology 2010;112:128-37. DOI PubMed
48. Tokmakoglu H. Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation.
Eur J Cardiothorac Surg 2002;21:401-5. DOI PubMed
49. Zebis LR, Christensen TD, Thomsen HF, et al. Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. Ann
Thorac Surg 2007;83:1326-31. DOI PubMed
50. Yagdi T, Nalbantgil S, Ayik F, et al. Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J
Thorac Cardiovasc Surg 2003;125:1420-5. DOI PubMed
51. Gillinov AM, Bagiella E, Moskowitz AJ, et al; CTSN. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N
Engl J Med 2016;374:1911-21. DOI PubMed PMC
52. Lewicki Ł, Siebert J, Rogowski J. Atrial fibrillation following off-pump versus on-pump coronary artery bypass grafting: incidence
and risk factors. Cardiol J 2016;23:518-23. DOI PubMed
53. Almassi GH, Pecsi SA, Collins JF, Shroyer AL, Zenati MA, Grover FL. Predictors and impact of postoperative atrial fibrillation on
patients' outcomes: a report from the Randomized On Versus Off Bypass trial. J Thorac Cardiovasc Surg 2012;143:93-102. DOI
PubMed
54. Gough WB, Zeiler RH, Barreca P, El-Sherif N. Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs.
J Cardiovasc Pharmacol 1982;4:375-80. DOI PubMed
55. Saul JP, LaPage MJ. Is it time to tell the emperor he has no clothes? Circ Arrhythm Electrophysiol 2010;3:115-7. DOI PubMed
56. Lindquist DE, Rowe AS, Heidel E, Fleming T, Yates JR. Evaluation of the hemodynamic effects of intravenous amiodarone
formulations during the maintenance phase infusion. Ann Pharmacother 2015;49:1317-21. DOI PubMed
57. Cushing DJ, Kowey PR, Cooper WD, Massey BW, Gralinski MR, Lipicky RJ. PM101: a cyclodextrin-based intravenous formulation
of amiodarone devoid of adverse hemodynamic effects. Eur J Pharmacol 2009;607:167-72. DOI PubMed
58. Ad N, Holmes SD, Patel J, et al. The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after
cardiac surgery. J Thorac Cardiovasc Surg 2017;153:597-605.e1. DOI PubMed